Mirnite 30 Tablet is a prescription-only medicine containing 30mg of mirtazapine, a tetracyclic antidepressant agent. It is indicated for the treatment of depression, particularly in patients who do not respond to selective serotonin reuptake inhibitors (SSRIs) or other antidepressant therapies. Mirtazapine works by selectively antagonizing the effects of serotonin and other neurotransmitters, thereby increasing their levels in the synaptic cleft and enhancing their activity. The therapeutic effects of Mirnite 30 Tablet may include improved mood, reduced symptoms of depression, and increased appetite. It is available in the form of tablets, which should be taken orally, usually once or twice daily, depending on the patient's response and the physician's discretion. The recommended starting dose is 15mg, with upward titration as needed. Common side effects include somnolence, dizziness, and increased appetite. Mirnite 30 Tablet should be used with caution in patients with a history of seizures, cardiovascular disease, or hepatic impairment. The medication should not be used in combination with MAO inhibitors, as this may lead to serotonin syndrome.